홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Dabrafenib Mesylate

HCID 44516822
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1195768-06-9
표준 SMILES
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O
InChIKey
YKGMKSIHIVVYKY-UHFFFAOYSA-N
분자식
C24H24F3N5O5S3
평균 분자량
615.7 g/mol
단동위원소 질량
615.08916689

개요

Dabrafenib mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma. It has a role as an antineoplastic agent and a B-Raf inhibitor. It contains a dabrafenib.

이름 및 식별자

우선 이름
Dabrafenib Mesylate
IUPAC
N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid
영어명
Dabrafenib Mesylate
분자식
C24H24F3N5O5S3
분자량
615.66

이름 및 동의어

Dabrafenib mesylate1195768-06-9TaflinarUNII-B6DC89I63EGSK 2118436BGSK-2118436BDabrafenib methanesulfonateGSK2118436BB6DC89I63Edabrafenib monomesylateGSK-2118436B MESYLATEGSK2118436 Methane sulfonate salt
이름 더 보기
N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide methanesulfonateDapafini mesylateabrafenibmesylateDabrfenib MesylateGSK2118436 MesylateGSK 2118436 MesylateGSK-2118436 MesylateDabrafenib Mesylate (API)
GSK2118436B, methane sulfonate saltGSK-2118436 METHANESULFONATE SALTGSK-2118436B METHANESULFONATE SALTCHEBI:75048DTXSID70152500Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1)BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)-2-FLUOROPHENYL)-2,6-DIFLUORO-, METHANESULFONATE (1:1)N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate

데이터베이스 식별자

CAS
1195768-06-9
PubChem CID
44516822
DTXSID
DTXSID70152500
ChEMBL
CHEMBL2105729
ChEBI
CHEBI:75048
UNII
B6DC89I63E
EC Number
689-167-4

물성

구조 계산 물성

극성 표면적
210 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
14
회전 가능 결합 수
6
무거운 원자 수
40
형식 전하
0
복잡도
910

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

물리화학적 성질

녹는점
234 oC · >234oC (dec.)
저장 조건
-20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
용해도
DMSO(약간 용해됨, 가열), 메탄올(약간 용해됨)
물리적 상태
백색 고체.
색상
흰색에서 황백색까지
안정성
흡습성
InChIKey
YKGMKSIHIVVYKY-UHFFFAOYSA-N
SMILES
S(O)(=O)(=O)C.FC1C(=CC=CC=1C1N=C(C(C)(C)C)SC=1C1C=CN=C(N)N=1)NS(C1C(=CC=CC=1F)F)(=O)=O

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H315 (66.7%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P260, P264, P264+P265, P273, P280, P302+P352, P305+P354+P338, P317, P318, P319, P321, P332+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesSkin Irrit. 2 (66.7%)

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Dabrafenib mesylate

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

안전 데이터

HS 번호
2935909099

화학 및 산업

응용 분야 · 2건

개요Dabrafenib mesylate, sold by GlaxoSmithKline under the trade name Tafinlar, was approved by the U.S. FDA in May 2013 for the treatment of metastatic BRAF-mutant melanoma. Dabrafenib reversibly inhibits the BRAF(V600E) mutant kinase as a selective ATP-competitive inhibitor which results in tumor regression.

용도Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.

상·하류 제품 정보

상류 원료

2,6-Difluorobenzenesulfonyl chlorideN-(3-(2-(2-chloropyriMidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonaMide다브라페닙N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonaMideMethyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoatemethyl 3-amino-2-fluorobenzoate메탄술폰산

추가 설명

정의ChEBI: A methanesulfonate (mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma.

관련 반응

5건
반응 기록 만들기
HRID 239380 반응식
HRID 239380생성물로
HRID 590152 반응식
HRID 590152생성물로
HRID 1196450 반응식
HRID 1196450반응물로
HRID 1671049 반응식
HRID 1671049생성물로
HRID 1961871 반응식
HRID 1961871생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트